BDPT
BioAdaptives, Inc.
0.0278
+0.0035+14.3%
Dec 15, 4:00:00 PM EST

Upcoming Earnings 

Report date
≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap
333.54K
P/E (TTM)
-
Basic EPS (TTM)
-0.06
Dividend Yield
0%

Recent Filings

About 

BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers Human Clinical trial; Zeranovia, a natural ingredient and uses proprietary methods of optimizing the availability of nutrients in foods and beverages; Lung Flute, a medical device; and Xcellara, PawPa, and MyndMed. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. The company was incorporated in 2013 and is based in Las Vegas, Nevada.

CEO
Mr. James E. Keener
IPO
6/1/2016
Employees
1
Sector
Consumer Defensive
Industry
Packaged Foods